In light of recent prescription drug recalls, US physicians and consumers alike are concerned about drug safety, agreeing that more should be done to monitor medicines for side effects after they are approved for market in order to ensure their safe use, according to the findings of a new survey conducted by Accenture.
The study, which questioned more than 100 physicians and 500 consumers, revealed that 67% of the doctors and 32% of consumers say that they have become more concerned about the safety of prescription medications since the recent removal from the US market, and elswhere, of the COX-2 inhibitors (Marketletters passim).
82% of doctors and 88% of consumers want more safety monitoring
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze